Ximedica Recapitalizes With SV Life Sciences
PROVIDENCE, R.I.--(BUSINESS WIRE)--Ximedica today announced that SV Life Sciences has acquired majority interest in the company from Co-Founders Stephen Lane and Aidan Petrie. Ximedica will maintain its headquarters in Providence, RI. President & CEO Randall S. Barko and the current management team will remain in place, and Aidan Petrie will continue in his role as Chief Innovation Officer. Paul LaViolette, Managing Partner and Chief Operating Officer at SV Life Sciences, will join as Chairman of Ximedica’s board. Terms of the transaction were not disclosed.
Ximedica is a full service ISO 13485 certified and FDA registered product development firm that focuses exclusively on the development and commercialization of medical devices. As a trusted innovation partner for over 25 years, Ximedica deploys an integrated, user-centered process that provides clients with a commercialized product that achieves a strong return on investment, adoption, market share and customer satisfaction.
Help employers find you! Check out all the jobs and post your resume.
Ximedica is a full service ISO 13485 certified and FDA registered product development firm that focuses exclusively on the development and commercialization of medical devices. As a trusted innovation partner for over 25 years, Ximedica deploys an integrated, user-centered process that provides clients with a commercialized product that achieves a strong return on investment, adoption, market share and customer satisfaction.
Help employers find you! Check out all the jobs and post your resume.